ID
12285
Description
Official Title: Phase II Pharmacokinetic Study to Assess the Age-dependency in the Clearance of Doxorubicin in Paediatric Patients With Solid Tumours and Leukaemia Analyze pharmacokinetics of doxorubicin in children with cancer. Furthermore investigate the predictive role of troponin and natriuretic peptides for anthracycline-induced cardiotoxicity. https://clinicaltrials.gov/ct2/show/NCT01095926 NCT01095926
Lien
https://clinicaltrials.gov/ct2/show/NCT01095926
Mots-clés
Versions (2)
- 02/11/2015 02/11/2015 -
- 27/09/2021 27/09/2021 -
Téléchargé le
2 novembre 2015
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Pharmacokinetic Study of Doxorubicin in Children With Cancer DRKS00003787 NCT01095926
Registration
- StudyEvent: ODM
Description
Tumour type
Description
Wilms tumour SIOP Wilms tumour study group (e.g. SIOP WT 2001)
Type de données
integer
Alias
- UMLS CUI [1]
- C0027708
Description
Neuroblastoma
Type de données
integer
Alias
- UMLS CUI [1]
- C0027819
Description
Ewing sarcoma
Type de données
integer
Alias
- UMLS CUI [1]
- C0553580
Description
Soft tissue sarcoma
Type de données
integer
Alias
- UMLS CUI [1]
- C0334449
Description
ALL
Type de données
integer
Alias
- UMLS CUI [1]
- C0027651
Description
Other
Type de données
integer
Alias
- UMLS CUI [1]
- C0027651
Description
Doxorubicin administration: time of infusion
Description
Inclusion criteria
Description
Patient ≤ 17 years of age
Type de données
boolean
Alias
- UMLS CUI [1]
- C0001779
Description
Patient shall receive at least two cycles of doxorubicin
Type de données
boolean
Alias
- UMLS CUI [1]
- C0013089
Description
Patient, parent(s) or legal representative has/have provided written informed consent to participate in the trial according to national regulations
Type de données
boolean
Alias
- UMLS CUI [1]
- C0021430
Description
Patient is enrolled in a national or European protocol
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
Life expectancy of at least 3 month
Type de données
boolean
Alias
- UMLS CUI [1]
- C0023671
Description
Karnofsky performance status of ≥ 70%
Type de données
boolean
Alias
- UMLS CUI [1]
- C3829424
Description
Additional blood withdrawal is acceptable for the patient
Type de données
boolean
Alias
- UMLS CUI [1]
- C0005834
Description
Assent of patient, if patient is able to (if not able: please enter „N.A.“)
Type de données
integer
Alias
- UMLS CUI [1]
- C1879749
Description
Exclusion criterion
Description
Footer module
Description
Date of registration
Type de données
date
Alias
- UMLS CUI [1]
- C2985881
Description
Name Investigator
Type de données
integer
Alias
- UMLS CUI [1]
- C2826892
Description
Signature Investigator
Type de données
integer
Alias
- UMLS CUI [1]
- C2346576
Similar models
Registration
- StudyEvent: ODM